Medication-Related Osteonecrosis of the Jaws Bisphosphonates, Denosumab, and New Agents /

• Συγγραφή απο Οργανισμό/Αρχή: SpringerLink (Online service)
• Άλλοι συγγραφείς: Otto, Sven (Επιμελητής έκδοσης)
• Μορφή: Ηλεκτρονική πηγή Ηλ. βιβλίο
• Γλώσσα: English
• Έκδοση: Berlin, Heidelberg : Springer Berlin Heidelberg : Imprint: Springer, 2015.
• Θέματα: Dentistry.; Medicine.; Oral surgery.; Maxillofacial surgery.; Medicine & Public Health.; Oral and Maxillofacial Surgery.

Osteonecrosis of the jaws is a well-known side-effect of antiresorptive therapy that predominantly occurs in patients suffering from malignant diseases and receiving intravenous administrations of nitrogen-containing bisphosphonates or subcutaneous administrations of denosumab, a monoclonal antibody...

Πίνακας περιεχομένων:

• Pharmacology of Antiresorptive Drugs
• The Role of Antiresorptive Drugs in the Treatment of Osteoporosis
• The Role of Antiresorptive Drugs in the Treatment of Skeletal Manifestations of Malignant Diseases
• Clinical Features, Localization, Definition and Staging of the Disease
• Radiological Findings / Imaging
• General Characteristics and Risk Factors for BRONJ
• Epidemiology
• Histopathology of BRONJ
• Prevention of Osteonecrosis and Dentoalveolar Surgery Under Treatment With Antiresorptive Drugs
• Bisphosphonates and Dental Implants
• Treatment of BRONJ
• Local and Microvascular Flaps in ONJ-Treatment
• Rehabilitation of Patients After BRONJ
• Adjuvant Treatment Strategies
• Microbiology and Antibiotics
• Animal Models of ONJ
• ONJ Under Denosumab and Other New Drugs
• Possible Use of Antiresorptive Drugs in OMS
• Dental Treatment Under BPs and After BRONJ
• Dental Rehabilitation Under Bisphosphonates and After BRONJ
• History of ONJ.